Moaath Mustafa Ali, Hematologist and Medical Oncologist, Leukemia specialist at Cleveland Clinic, shared a post on LinkedIn:
“I am honored to share that I was nominated by the American Society of Hematology to serve as a speaker in the 2026 edition of the Evidence-Based Hematology course.
Topic: Acute Myeloid Leukemia for the Agrupación Mexicana para el Estudio de la Hematología AC (AMEH), a leading hematology society based in Mexico dedicated to advancing education, research, and clinical excellence across the region.
This fully online international academic program is designed to strengthen clinical decision-making through the critical appraisal of the best available scientific evidence. The course covers more than 50 hematology topics organized into thematic modules, integrating literature review with practical, case-based discussions to enhance real-world application.
Grateful for the opportunity to contribute to both regional and international efforts aimed at advancing evidence-based hematology and improving outcomes for patients with hematologic malignancies.”
More posts featuring The American Society of Hematology on OncoDaily.